13 Alzheimer's Disease Misconceptions—and the Truth Behind Them
Medically reviewed by Dr. Ari Magill First described by Alois Alzheimer in 1906, Alzheimer's disease (AD) is a ...
Stay updated with breaking news from Memory Disorders Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medically reviewed by Dr. Ari Magill First described by Alois Alzheimer in 1906, Alzheimer's disease (AD) is a ...
07.06.2022 - BOTHELL, Wash., June 07, 2022 (GLOBE NEWSWIRE) - Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced the ... Seite 1
There are over five million Americans struggling with dementia and the numbers are expected to rise as the aging population grows.
Published: Jan 20, 2021 CLARKSVILLE, Md., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Neuronascent Inc., a privately-held neuron regeneration therapeutics company, today announced the publication of results of their novel pharmacotherapy: NNI-362 to allosterically stimulate neural regeneration in human cultures and in vivo models of aging and disease. This small molecule therapy is presently in Phase 1 clinical trial for mild to moderate Alzheimer’s disease (AD), which is supported by a NIA R01 grant in healthy aged volunteers. The short report in the Stem Cell Research & Therapy journal https:...